Ram Krishnan

Company: Sanofi

Job title: Head of Neurodegenerative Disease Cluster

Seminars:

WORKSHOP B
APPROACHES FOR TACKLING NEURODEGENERATIVE DISEASE TO ASSESS DRUG IMPACTS FOR BETTER FUTURE DEVELOPMENT 1:30 pm - 4:30 pm

Reviewing the previous research and the current approaches is crucial to the development of novel methodologies and advancing drugs to clinic Workshop highlights include: Assessing the current treatments and therapies for CNS diseases to recognize where improvements can be made for better drug development Understanding the difficulties in curing neurodegenerative diseases to rethink approaches and…Read more

day: WORKSHOP B

Navigating the Next Steps in Neurodegenerative Therapies: Assessing Drug Safety, Regulations & Progressing Through Trials to Get Protein Degrader Drugs to Clinic to Improve the Treatment of CNS Disease 9:30 am

In vitro and in vivo safety and toxicity profiling – overview of the methodologies able to assess safety, toxicity and off-target effects as well as selecting appropriate biomarkers for progressing to clinical trials Current regulatory landscape for protein degrader therapies – regulatory requirements and guidelines that need to be met to get approval for use…Read more

day: Conference Day One